These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 33044959

  • 1. Adults from Kisumu, Kenya have robust γδ T cell responses to Schistosoma mansoni, which are modulated by tuberculosis.
    McLaughlin TA, Khayumbi J, Ongalo J, Matete D, Tonui J, Muchiri B, Sasser LE, Campbell A, Allana S, Ouma SG, Hayara FO, Gandhi NR, Day CL.
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008764. PubMed ID: 33044959
    [Abstract] [Full Text] [Related]

  • 2. CD4 T Cells in Mycobacterium tuberculosis and Schistosoma mansoni Co-infected Individuals Maintain Functional TH1 Responses.
    McLaughlin TA, Khayumbi J, Ongalo J, Tonui J, Campbell A, Allana S, Gurrion Ouma S, Odhiambo FH, Gandhi NR, Day CL.
    Front Immunol; 2020 Oct; 11():127. PubMed ID: 32117277
    [Abstract] [Full Text] [Related]

  • 3. Schistosoma mansoni Infection Is Associated With a Higher Probability of Tuberculosis Disease in HIV-Infected Adults in Kenya.
    McLaughlin TA, Nizam A, Hayara FO, Ouma GS, Campbell A, Khayumbi J, Ongalo J, Ouma SG, Shah NS, Altman JD, Kaushal D, Rengarajan J, Ernst JD, Blumberg HM, Waller LA, Gandhi NR, Day CL, Benkeser D.
    J Acquir Immune Defic Syndr; 2021 Feb 01; 86(2):157-163. PubMed ID: 33074856
    [Abstract] [Full Text] [Related]

  • 4. Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.
    Zhang W, Ahmad G, Torben W, Noor Z, Le L, Damian RT, Wolf RF, White GL, Chavez-Suarez M, Podesta RB, Kennedy RC, Siddiqui AA.
    J Infect Dis; 2010 Apr 01; 201(7):1105-12. PubMed ID: 20187746
    [Abstract] [Full Text] [Related]

  • 5. Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus Toxoid.
    Riner DK, Ndombi EM, Carter JM, Omondi A, Kittur N, Kavere E, Korir HK, Flaherty B, Karanja D, Colley DG.
    PLoS Negl Trop Dis; 2016 Dec 01; 10(12):e0005180. PubMed ID: 27926921
    [Abstract] [Full Text] [Related]

  • 6. Development of antibody isotype responses to Schistosoma mansoni in an immunologically naive immigrant population: influence of infection duration, infection intensity, and host age.
    Naus CW, Kimani G, Ouma JH, Fulford AJ, Webster M, van Dam GJ, Deelder AM, Butterworth AE, Dunne DW.
    Infect Immun; 1999 Jul 01; 67(7):3444-51. PubMed ID: 10377125
    [Abstract] [Full Text] [Related]

  • 7. The effect of maternal helminth infection on maternal and neonatal immune function and immunity to tuberculosis.
    Gebreegziabiher D, Desta K, Desalegn G, Howe R, Abebe M.
    PLoS One; 2014 Jul 01; 9(4):e93429. PubMed ID: 24710174
    [Abstract] [Full Text] [Related]

  • 8. Helminth Antigen Exposure Enhances Early Immune Control of Mycobacterium tuberculosis in Monocytes and Macrophages.
    Togarsimalemath SK, Pushpamithran G, Schön T, Stendahl O, Blomgran R.
    J Innate Immun; 2021 Jul 01; 13(3):148-163. PubMed ID: 33333522
    [Abstract] [Full Text] [Related]

  • 9. Necator americanus and helminth co-infections: further down-modulation of hookworm-specific type 1 immune responses.
    Geiger SM, Alexander ND, Fujiwara RT, Brooker S, Cundill B, Diemert DJ, Correa-Oliveira R, Bethony JM.
    PLoS Negl Trop Dis; 2011 Sep 01; 5(9):e1280. PubMed ID: 21909439
    [Abstract] [Full Text] [Related]

  • 10. Application of adult worm and lung-stage antigens to immunize against Schistosoma mansoni using cytokines as adjuvants.
    Afifi MA, El-Wakil HS, Abdel-Ghaffar MM, Mohamed RT.
    J Egypt Soc Parasitol; 2006 Apr 01; 36(1):351-62, 2p following 362. PubMed ID: 16605124
    [Abstract] [Full Text] [Related]

  • 11. Species-Specific Serological Detection for Schistosomiasis by Serine Protease Inhibitor (SERPIN) in Multiplex Assay.
    Tanigawa C, Fujii Y, Miura M, Nzou SM, Mwangi AW, Nagi S, Hamano S, Njenga SM, Mbanefo EC, Hirayama K, Mwau M, Kaneko S.
    PLoS Negl Trop Dis; 2015 Apr 01; 9(8):e0004021. PubMed ID: 26291988
    [Abstract] [Full Text] [Related]

  • 12. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis.
    Elias D, Akuffo H, Pawlowski A, Haile M, Schön T, Britton S.
    Vaccine; 2005 Feb 03; 23(11):1326-34. PubMed ID: 15661380
    [Abstract] [Full Text] [Related]

  • 13. The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
    Wajja A, Kizito D, Nassanga B, Nalwoga A, Kabagenyi J, Kimuda S, Galiwango R, Mutonyi G, Vermaak S, Satti I, Verweij J, Tukahebwa E, Cose S, Levin J, Kaleebu P, Elliott AM, McShane H.
    PLoS Negl Trop Dis; 2017 May 03; 11(5):e0005440. PubMed ID: 28472067
    [Abstract] [Full Text] [Related]

  • 14. Cytokine and chemokine expression profiles in response to Mycobacterium tuberculosis stimulation are altered in HIV-infected compared to HIV-uninfected subjects with active tuberculosis.
    Waruk JL, Machuki Z, Mesa C, Juno JA, Anzala O, Sharma M, Ball TB, Oyugi J, Kiazyk S.
    Tuberculosis (Edinb); 2015 Sep 03; 95(5):555-61. PubMed ID: 26073895
    [Abstract] [Full Text] [Related]

  • 15. Effect of different stages of Schistosoma mansoni infection on the parasite burden and immune response to Strongyloides venezuelensis in co-infected mice.
    de Rezende MC, Araújo ES, Moreira JM, Rodrigues VF, Rodrigues JL, Pereira CA, Negrão-Corrêa D.
    Parasitol Res; 2015 Dec 03; 114(12):4601-16. PubMed ID: 26350380
    [Abstract] [Full Text] [Related]

  • 16. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
    Farah IO, Johansson M, Lövgren-Bengtson K, Hau J.
    Scand J Immunol; 2000 Mar 03; 51(3):237-43. PubMed ID: 10736092
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
    Ricciardi A, Dalton JP, Ndao M.
    Vaccine; 2015 Jan 03; 33(2):346-53. PubMed ID: 25448114
    [Abstract] [Full Text] [Related]

  • 18. Gestation and breastfeeding in schistosomotic mothers differently modulate the immune response of adult offspring to postnatal Schistosoma mansoni infection.
    Santos Pd, Lorena VM, Fernandes Éde S, Sales IR, Nascimento WR, Gomes Yde M, Albuquerque MC, Costa VM, Souza VM.
    Mem Inst Oswaldo Cruz; 2016 Feb 03; 111(2):83-92. PubMed ID: 26872339
    [Abstract] [Full Text] [Related]

  • 19. CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14KDA Schistosoma mansoni fatty acid-binding protein.
    Brito CF, Caldas IR, Coura Filho P, Correa-Oliveira R, Oliveira SC.
    Scand J Immunol; 2000 Jun 03; 51(6):595-601. PubMed ID: 10849370
    [Abstract] [Full Text] [Related]

  • 20. Immunization with adult Schistosoma mansoni tegument, treated with sub-curative praziquantel, partially protects mice against the infection.
    El-Aswad BEW, Harba NM, Moharm IM, Mahmoud SF.
    J Helminthol; 2019 Jan 31; 94():e26. PubMed ID: 30702051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.